Matches in SCALES for { <scales/DocketEntry/ilnd;;1:11-cv-03318_de340> ?p ?o ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- ilnd;;1:11-cv-03318_de340 RegisterActionDate "2014-07-17" @default.
- ilnd;;1:11-cv-03318_de340 RegisterActionDescriptionText "CORRECTED MEMORANDUM OPINION AND ORDER signed by the Honorable Matthew F. Kennelly on 7/17/2014 (this corrects a scrivener's error in the "Conclusion" section of the memorandum opinion issued earlier today): MEMORANDUM OPINION AND ORDER signed by the Honorable Matthew F. Kennelly on 7/17/2014: For the reasons stated in this decision, the Court denies Merix's motion for summary judgment [dkt. nos. 273 & 279]; grants CSM's motion for summary judgment [dkt. nos. 270 & 283] as to counts 5 (breach of confidential disclosure agreement), 7 (breach of master services agreement), 8 (conspiracy), and 9 (negligent spoliation) in Merix's Fourth Amended Complaint; and grants CSM's motion for summary judgment on consequential damages [dkt. no. 285] on all but Merix's claim for damages incurred in its defense of GSK's New Jersey lawsuit. The Court also terminates as moot Merix's motion for relief from Local Rule 56.1(b)(3) [dkt. No. 322] because the Court has not taken CSM's invitation to grant summary judgment or find various matters to be admitted based on noncompliance with the rule. The Court also terminates defendants' motions to bar the testimony of certain expert witnesses [dkt. nos. 266, 267, 287 & 288] in light of the rulings made on the summary judgment motions. The case remains set for a status hearing on Monday, July 21, 2014 at 9:30 a.m. Counsel should be prepared to discuss the anticipated length of the trial in light of the Court's rulings. (mk) (Kennelly, Matthew) (Entered: 07/17/2014)" @default.
- ilnd;;1:11-cv-03318_de340 AdministrativeID "338" @default.